Cargando…
A case of Guillain-Barre syndrome after the second dose of AstraZeneca COVID-19 vaccination
Coronavirus disease 2019 (COVID-19) is a novel virus that primarily involves the respiratory system. Due to the COVID-19 pandemic, an extensive vaccination program is underway worldwide. Herein, we present a 68-year-old woman with paresthesia of both hands associated with gait instability, which sta...
Autores principales: | Bazrafshan, Hanieh, Mohamadi Jahromi, Leila Sadat, Parvin, Reyhaneh, Ashraf, Alireza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bayçınar Medical Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366477/ https://www.ncbi.nlm.nih.gov/pubmed/35989967 http://dx.doi.org/10.5606/tftrd.2022.9984 |
Ejemplares similares
-
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
por: Oo, Wai M., et al.
Publicado: (2021) -
Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?
por: Introna, Alessandro, et al.
Publicado: (2021) -
Morbilliform Eruption After Administration of Second Dose of Oxford/AstraZeneca Vaccine
por: Alhammad, Norah S, et al.
Publicado: (2022) -
Guillain-Barré syndrome following the second dose of COVID AstraZeneca vaccine in a 78-year-old male: a case report from Nepal
por: Acharya, Bimarsh, et al.
Publicado: (2023) -
AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021)